Altimmune, Inc. (ALT)

USD 7.9

(-5.95%)

Total Debt Summary of Altimmune, Inc.

  • Altimmune, Inc.'s latest annual total debt in 2023 was 671 Thousand USD , down -40.3% from previous year.
  • Altimmune, Inc.'s latest quarterly total debt in 2024 Q2 was 1.86 Million USD , up 237.32% from previous quarter.
  • Altimmune, Inc. reported annual total debt of 1.12 Million USD in 2022, down -26.78% from previous year.
  • Altimmune, Inc. reported annual total debt of 1.53 Million USD in 2021, down -15.88% from previous year.
  • Altimmune, Inc. reported quarterly total debt of 1.86 Million USD for 2024 Q2, up 237.32% from previous quarter.
  • Altimmune, Inc. reported quarterly total debt of 671 Thousand USD for 2023 Q4, down -14.85% from previous quarter.

Annual Total Debt Chart of Altimmune, Inc. (2023 - 2005)

Historical Annual Total Debt of Altimmune, Inc. (2023 - 2005)

Year Total Debt Total Debt Growth
2023 671 Thousand USD -40.3%
2022 1.12 Million USD -26.78%
2021 1.53 Million USD -15.88%
2020 1.82 Million USD 4.63%
2019 1.74 Million USD 204.51%
2018 572.77 Thousand USD 1052.41%
2017 49.7 Thousand USD -94.95%
2016 984.58 Thousand USD -9.09%
2015 1.08 Million USD 45.14%
2014 746.14 Thousand USD -73.56%
2013 2.82 Million USD -25.43%
2012 3.78 Million USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 17.42 Million USD -4.8%
2008 18.3 Million USD -11.43%
2007 20.66 Million USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Total Debt Comparison of Altimmune, Inc.

Name Total Debt Total Debt Difference
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Adaptive Biotechnologies Corporation 229.43 Million USD 99.708%
IO Biotech, Inc. 2.49 Million USD 73.095%
VYNE Therapeutics Inc. 214 Thousand USD -213.551%
Organovo Holdings, Inc. 1.39 Million USD 51.865%
TNF Pharmaceuticals, Inc. 48.87 Thousand USD -1273.03%
Lexaria Bioscience Corp. 163.96 Thousand USD -309.229%
Tonix Pharmaceuticals Holding Corp. 9.81 Million USD 93.162%
Aadi Bioscience, Inc. 7.02 Million USD 90.447%
Savara Inc. 26.73 Million USD 97.49%
Aerovate Therapeutics, Inc. 675 Thousand USD 0.593%
Rocket Pharmaceuticals, Inc. 25.04 Million USD 97.321%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD 96.787%
ZyVersa Therapeutics, Inc. 8656.00 USD -7651.848%
Soligenix, Inc. 3.49 Million USD 80.799%
Aptose Biosciences Inc. 1 Million USD 33.552%
NKGen Biotech, Inc. Common Stock 19.92 Million USD 96.632%
Century Therapeutics, Inc. 48.17 Million USD 98.607%
Eterna Therapeutics Inc. 41.84 Million USD 98.396%
Precision BioSciences, Inc. 31.26 Million USD 97.854%
Axsome Therapeutics, Inc. 186.37 Million USD 99.64%
Kura Oncology, Inc. 17.2 Million USD 96.099%
Xenetic Biosciences, Inc. - USD -Infinity%
Dyadic International, Inc. 136.92 Thousand USD -390.035%
TScan Therapeutics, Inc. 92.43 Million USD 99.274%
IDEAYA Biosciences, Inc. 2.87 Million USD 76.636%
CytomX Therapeutics, Inc. 13.97 Million USD 95.198%
Autolus Therapeutics plc 52.96 Million USD 98.733%
Eton Pharmaceuticals, Inc. 5.45 Million USD 87.699%
EyePoint Pharmaceuticals, Inc. 5.46 Million USD 87.731%
GRI Bio, Inc. 14 Thousand USD -4692.857%
Tenaya Therapeutics, Inc. 12.42 Million USD 94.599%
IGM Biosciences, Inc. 40.5 Million USD 98.343%
Heron Therapeutics, Inc. 179.62 Million USD 99.626%
SAB Biotherapeutics, Inc. 5.9 Million USD 88.641%
Entero Therapeutics, Inc. 826.84 Thousand USD 18.848%
Opthea Limited 200.62 Million USD 99.666%
X4 Pharmaceuticals, Inc. 58.28 Million USD 98.849%
Atara Biotherapeutics, Inc. 57.87 Million USD 98.841%
Pliant Therapeutics, Inc. 11.37 Million USD 94.1%
Ligand Pharmaceuticals Incorporated 6.16 Million USD 89.116%
Surrozen, Inc. 3.37 Million USD 80.142%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cingulate Inc. 3.13 Million USD 78.597%
Ovid Therapeutics Inc. 46 Million USD 98.541%
Sorrento Therapeutics, Inc. 134.5 Million USD 99.501%
Acelyrin, Inc. 1.19 Million USD 43.802%
Centessa Pharmaceuticals plc 84.58 Million USD 99.207%
Hepion Pharmaceuticals, Inc. 209.02 Thousand USD -221.022%
Arcturus Therapeutics Holdings Inc. 30.21 Million USD 97.779%
Syros Pharmaceuticals, Inc. 62.07 Million USD 98.919%
ADMA Biologics, Inc. 141.41 Million USD 99.526%
PureTech Health plc 25.51 Million USD 97.37%
Oncternal Therapeutics, Inc. 318 Thousand USD -111.006%
FibroBiologics, Inc. Common Stock 1.74 Million USD 61.591%
Barinthus Biotherapeutics plc 12.97 Million USD 94.829%
Kymera Therapeutics, Inc. 84.67 Million USD 99.208%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd 247 Thousand USD -171.66%
ChromaDex Corporation 3.27 Million USD 79.524%
Inhibikase Therapeutics, Inc. 622 Thousand USD -7.877%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 189.94 Million USD 99.647%
Akebia Therapeutics, Inc. 104.18 Million USD 99.356%
Better Therapeutics, Inc. 14.88 Million USD 95.491%
Nurix Therapeutics, Inc. 30.61 Million USD 97.808%
Apellis Pharmaceuticals, Inc. 110.92 Million USD 99.395%
Sangamo Therapeutics, Inc. 38.1 Million USD 98.239%
Seer, Inc. 28.25 Million USD 97.626%
Aridis Pharmaceuticals, Inc. 6.13 Million USD 89.054%
LAVA Therapeutics N.V. 6.31 Million USD 89.371%
Gritstone bio, Inc. 104.77 Million USD 99.36%
Jasper Therapeutics, Inc. 2.78 Million USD 75.915%
Avid Bioservices, Inc. 207.83 Million USD 99.677%
Insmed Incorporated 1.2 Billion USD 99.944%
Panbela Therapeutics, Inc. 5.19 Million USD 87.081%
Avalo Therapeutics, Inc. 3.9 Million USD 82.808%
Fate Therapeutics, Inc. 103.53 Million USD 99.352%
MediWound Ltd. 6.71 Million USD 90.001%
BioXcel Therapeutics, Inc. 101.38 Million USD 99.338%
Fortress Biotech, Inc. 88.59 Million USD 99.243%
OmniAb, Inc. 25.56 Million USD 97.375%
Seres Therapeutics, Inc. 213.93 Million USD 99.686%
Zai Lab Limited 15.15 Million USD 95.571%
Revance Therapeutics, Inc. 478.43 Million USD 99.86%
Tarsus Pharmaceuticals, Inc. 31.73 Million USD 97.885%
Veracyte, Inc. 12.63 Million USD 94.687%
Abeona Therapeutics Inc. 5.4 Million USD 87.574%
FibroGen, Inc. 170.45 Million USD 99.606%
Apogee Therapeutics, Inc. 2.03 Million USD 67.011%
ContextLogic Inc. 6 Million USD 88.817%
Intensity Therapeutics, Inc. 158 Thousand USD -324.684%
Adial Pharmaceuticals, Inc. - USD -Infinity%
HOOKIPA Pharma Inc. 6.55 Million USD 89.77%
Jazz Pharmaceuticals plc 5.79 Billion USD 99.988%
Entrada Therapeutics, Inc. 68.23 Million USD 99.017%
Cyclacel Pharmaceuticals, Inc. 37 Thousand USD -1713.514%
ImmuCell Corporation 11.96 Million USD 94.394%
Fortrea Holdings Inc. 1.67 Billion USD 99.96%
KalVista Pharmaceuticals, Inc. 7.31 Million USD 90.83%
Jasper Therapeutics, Inc. 2.78 Million USD 75.915%
Foghorn Therapeutics Inc. 45.07 Million USD 98.511%
Ultragenyx Pharmaceutical Inc. 43.16 Million USD 98.446%
Theravance Biopharma, Inc. 45.23 Million USD 98.517%
Metagenomi, Inc. Common Stock 48.22 Million USD 98.609%
Vaxxinity, Inc. 15.16 Million USD 95.576%
BioCryst Pharmaceuticals, Inc. 848.71 Million USD 99.921%
Gain Therapeutics, Inc. 1.02 Million USD 34.689%
Creative Medical Technology Holdings, Inc. 14.19 Thousand USD -4627.35%
Marker Therapeutics, Inc. - USD -Infinity%
CASI Pharmaceuticals, Inc. 21.23 Million USD 96.841%
Senti Biosciences, Inc. 37.66 Million USD 98.219%
BioRestorative Therapies, Inc. 162.31 Thousand USD -313.389%
Apollomics, Inc. 4.66 Million USD 85.604%
89bio, Inc. 27.1 Million USD 97.525%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 99.417%
TransCode Therapeutics, Inc. 450.57 Thousand USD -48.922%
RAPT Therapeutics, Inc. 6.9 Million USD 90.284%
Ardelyx, Inc. 55.98 Million USD 98.801%
Pluri Inc. 29.61 Million USD 97.734%
Prothena Corporation plc 11.83 Million USD 94.33%
Pulmatrix, Inc. 8.75 Million USD 92.337%
Celularity Inc. 65.41 Million USD 98.974%
MeiraGTx Holdings plc 89.26 Million USD 99.248%
Omeros Corporation 338.28 Million USD 99.802%
Ainos, Inc. 5.96 Million USD 88.748%
Humacyte, Inc. 58.1 Million USD 98.845%
Mesoblast Limited 118.92 Million USD 99.436%
Cocrystal Pharma, Inc. 1.85 Million USD 63.788%
Cidara Therapeutics, Inc. 4.87 Million USD 86.242%
Blueprint Medicines Corporation 774.12 Million USD 99.913%
Cabaletta Bio, Inc. 5.01 Million USD 86.628%
Summit Therapeutics Inc. 106.09 Million USD 99.368%
Alaunos Therapeutics, Inc. - USD -Infinity%
Scholar Rock Holding Corporation 61.81 Million USD 98.915%
Intellia Therapeutics, Inc. 115.34 Million USD 99.418%
Adlai Nortye Ltd. American Depositary Shares 31.54 Million USD 97.873%
Cytokinetics, Incorporated 755.77 Million USD 99.911%
Eloxx Pharmaceuticals, Inc. 13.38 Million USD 94.987%
Nutriband Inc. 241.28 Thousand USD -178.094%
Protara Therapeutics, Inc. 5.46 Million USD 87.726%
Roivant Sciences Ltd. 499.74 Million USD 99.866%
Evogene Ltd. 1.13 Million USD 41.037%
Applied Therapeutics, Inc. 1.22 Million USD 45.269%
Hoth Therapeutics, Inc. 55.16 Thousand USD -1116.351%
BridgeBio Pharma, Inc. 1.73 Billion USD 99.961%
BioLineRx Ltd. 11.59 Million USD 94.211%
Atai Life Sciences N.V. 16.47 Million USD 95.927%
VistaGen Therapeutics, Inc. 2.12 Million USD 68.349%
Aurinia Pharmaceuticals Inc. 97.6 Million USD 99.313%
MediciNova, Inc. 215.92 Thousand USD -210.755%
Praxis Precision Medicines, Inc. 2.49 Million USD 73.106%
MiMedx Group, Inc. 48.09 Million USD 98.605%
PTC Therapeutics, Inc. 415.02 Million USD 99.838%
Cullinan Oncology, Inc. 3.59 Million USD 81.309%
Syndax Pharmaceuticals, Inc. 1.63 Million USD 58.96%
Pasithea Therapeutics Corp. 81.68 Thousand USD -721.499%
NRx Pharmaceuticals, Inc. 9.16 Million USD 92.675%
4D Molecular Therapeutics, Inc. 14.67 Million USD 95.426%
Dyne Therapeutics, Inc. 27.41 Million USD 97.552%
Kiniksa Pharmaceuticals, Ltd. 12.25 Million USD 94.526%
Ventyx Biosciences, Inc. 12.5 Million USD 94.635%
Allakos Inc. 41.46 Million USD 98.382%
Fulcrum Therapeutics, Inc. 10.82 Million USD 93.799%
Corcept Therapeutics Incorporated 151 Thousand USD -344.371%
BioAtla, Inc. 2.46 Million USD 72.724%
Allogene Therapeutics, Inc. 95.12 Million USD 99.295%
Larimar Therapeutics, Inc. 5.54 Million USD 87.901%
Precigen, Inc. 7.09 Million USD 90.545%
BriaCell Therapeutics Corp. - USD -Infinity%
XOMA Corporation 124.45 Million USD 99.461%
Kezar Life Sciences, Inc. 18.93 Million USD 96.456%
Incyte Corporation 38.28 Million USD 98.247%
Cara Therapeutics, Inc. 43.16 Million USD 98.446%
Aligos Therapeutics, Inc. 11.13 Million USD 93.976%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 238.63 Million USD 99.719%
Akero Therapeutics, Inc. 26.04 Million USD 97.423%
Eliem Therapeutics, Inc. 349 Thousand USD -92.264%
EyeGate Pharmaceuticals, Inc. 326.49 Thousand USD -105.517%
UroGen Pharma Ltd. 100.21 Million USD 99.33%
Sutro Biopharma, Inc. 182.74 Million USD 99.633%
ZIVO Bioscience, Inc. 346.34 Thousand USD -93.739%
Lisata Therapeutics, Inc. 305 Thousand USD -120.0%
Stoke Therapeutics, Inc. 6.83 Million USD 90.183%
Chimerix, Inc. 2.14 Million USD 68.703%
Outlook Therapeutics, Inc. 35.55 Million USD 98.113%
60 Degrees Pharmaceuticals, Inc. 172.67 Thousand USD -288.596%
Enanta Pharmaceuticals, Inc. 26.51 Million USD 97.469%
Aprea Therapeutics, Inc. - USD -Infinity%
Portage Biotech Inc. 47 Thousand USD -1327.66%
OncoCyte Corporation 2.86 Million USD 76.612%
Qualigen Therapeutics, Inc. 1.29 Million USD 48.353%
Cadrenal Therapeutics, Inc. Common Stock 21.35 Thousand USD -3042.857%
Processa Pharmaceuticals, Inc. 150.55 Thousand USD -345.687%
Purple Biotech Ltd. 351 Thousand USD -91.168%
NextCure, Inc. 6.6 Million USD 89.841%
ProMIS Neurosciences, Inc. - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Generation Bio Co. 97.89 Million USD 99.315%
Neumora Therapeutics, Inc. Common Stock 5.23 Million USD 87.173%
Xeris Biopharma Holdings, Inc. 229.19 Million USD 99.707%
TRACON Pharmaceuticals, Inc. 968 Thousand USD 30.682%
NLS Pharmaceutics AG 1.63 Million USD 58.929%
Mineralys Therapeutics, Inc. - USD -Infinity%
Novavax, Inc. 280.63 Million USD 99.761%
Virios Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 2.79 Million USD 75.984%
Daré Bioscience, Inc. 5.31 Million USD 87.383%
Titan Pharmaceuticals, Inc. 565 Thousand USD -18.761%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Bicycle Therapeutics plc 44.95 Million USD 98.507%
BeiGene, Ltd. 930.18 Million USD 99.928%
Kiromic BioPharma, Inc. 15.54 Million USD 95.683%
Alector, Inc. 38.91 Million USD 98.276%
Protagonist Therapeutics, Inc. 1.14 Million USD 41.192%
Erasca, Inc. 55.85 Million USD 98.799%
Checkpoint Therapeutics, Inc. - USD -Infinity%
Aura Biosciences, Inc. 19.55 Million USD 96.569%
Viracta Therapeutics, Inc. 25.55 Million USD 97.374%
Chemomab Therapeutics Ltd. 392 Thousand USD -71.173%
Protagenic Therapeutics, Inc. - USD -Infinity%
Pieris Pharmaceuticals, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 99.941%
Histogen Inc. 4.62 Million USD 85.482%
Fortress Biotech, Inc. 88.59 Million USD 99.243%
Avidity Biosciences, Inc. 9.85 Million USD 93.189%
Lyell Immunopharma, Inc. 63.16 Million USD 98.938%
Galecto, Inc. 249 Thousand USD -169.478%
InMed Pharmaceuticals Inc. 644.86 Million USD 99.896%
Phathom Pharmaceuticals, Inc. 139.03 Million USD 99.517%
Molecular Templates, Inc. 12.23 Million USD 94.513%
PDS Biotechnology Corporation 23.85 Million USD 97.187%
Amylyx Pharmaceuticals, Inc. 4.23 Million USD 84.163%
Amarin Corporation plc 8.73 Million USD 92.32%
TG Therapeutics, Inc. 110.79 Million USD 99.394%
Aptevo Therapeutics Inc. 5.39 Million USD 87.567%
Celldex Therapeutics, Inc. 2.54 Million USD 73.603%
Cogent Biosciences, Inc. 18.85 Million USD 96.441%
Onconetix, Inc. 9.88 Million USD 93.212%
MacroGenics, Inc. 33.97 Million USD 98.025%
Y-mAbs Therapeutics, Inc. 1.41 Million USD 52.713%
Ocuphire Pharma, Inc. - USD -Infinity%
Adagene Inc. 22.3 Million USD 96.992%
Inhibrx Biosciences, Inc. 210.14 Million USD 99.681%
Cartesian Therapeutics, Inc. 10.95 Million USD 93.875%
Voyager Therapeutics, Inc. 20.29 Million USD 96.693%
SciSparc Ltd. 76 Thousand USD -782.895%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. 82.01 Million USD 99.182%
Astria Therapeutics, Inc. 329 Thousand USD -103.951%
Black Diamond Therapeutics, Inc. 25.29 Million USD 97.348%
Arcutis Biotherapeutics, Inc. 205.91 Million USD 99.674%
Relay Therapeutics, Inc. 53.46 Million USD 98.745%
Alnylam Pharmaceuticals, Inc. 2.68 Billion USD 99.975%
Psyence Biomedical Ltd. 7.65 Million USD 91.237%
Artelo Biosciences, Inc. 63 Thousand USD -965.079%
2seventy bio, Inc. 256.67 Million USD 99.739%
Clene Inc. 32.16 Million USD 97.914%
Boundless Bio, Inc. Common Stock 2.19 Million USD 69.431%
GeoVax Labs, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 203.91 Thousand USD -229.065%
Arbutus Biopharma Corporation 8.72 Million USD 92.306%
Scopus BioPharma Inc. - USD -Infinity%
Absci Corporation 15.95 Million USD 95.795%
XBiotech Inc. - USD -Infinity%
ALX Oncology Holdings Inc. 17.19 Million USD 96.098%
Lyra Therapeutics, Inc. 26.88 Million USD 97.504%
Entera Bio Ltd. 390 Thousand USD -72.051%
Trevena, Inc. 35.23 Million USD 98.096%
Adaptimmune Therapeutics plc 25.23 Million USD 97.341%
Caribou Biosciences, Inc. 27.48 Million USD 97.559%
INmune Bio, Inc. 10.43 Million USD 93.571%
Citius Pharmaceuticals, Inc. 481.24 Thousand USD -39.43%
Tyra Biosciences, Inc. 6.49 Million USD 89.671%
Galmed Pharmaceuticals Ltd. 41 Thousand USD -1536.585%
Unity Biotechnology, Inc. 26.99 Million USD 97.514%
Tenax Therapeutics, Inc. 500.9 Thousand USD -33.958%
Jaguar Health, Inc. 35.86 Million USD 98.129%
Clearside Biomedical, Inc. 43 Million USD 98.44%
NexImmune, Inc. 68.8 Thousand USD -875.163%
Connect Biopharma Holdings Limited 465 Thousand USD -44.301%
Clearmind Medicine Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. 1.22 Million USD 45.19%
Kronos Bio, Inc. 28.27 Million USD 97.627%
Innoviva, Inc. 449.07 Million USD 99.851%
Coherus BioSciences, Inc. 480.84 Million USD 99.86%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 99.975%
Bolt Biotherapeutics, Inc. 20.21 Million USD 96.681%
Verastem, Inc. 41.55 Million USD 98.385%
ProKidney Corp. 4.41 Million USD 84.795%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 56.849%
Imunon, Inc. 1.62 Million USD 58.7%
Viking Therapeutics, Inc. 1.26 Million USD 46.746%
Statera Biopharma, Inc. 16.26 Million USD 95.874%
ImmunityBio, Inc. 883.67 Million USD 99.924%
Korro Bio, Inc. 33.2 Million USD 97.979%
Travere Therapeutics, Inc. 404.78 Million USD 99.834%
Kineta, Inc. 1.31 Million USD 49.051%
Catalyst Pharmaceuticals, Inc. 3.55 Million USD 81.136%
Capricor Therapeutics, Inc. 5.61 Million USD 88.044%
GT Biopharma, Inc. 58 Thousand USD -1056.897%
Keros Therapeutics, Inc. 14.44 Million USD 95.354%
Celularity Inc. 65.41 Million USD 98.974%
Crinetics Pharmaceuticals, Inc. 51.72 Million USD 98.703%
CalciMedica, Inc. - USD -Infinity%
Cibus, Inc. 24.62 Million USD 97.275%
C4 Therapeutics, Inc. 70.97 Million USD 99.055%
Marinus Pharmaceuticals, Inc. 110.35 Million USD 99.392%
Eledon Pharmaceuticals, Inc. 383 Thousand USD -75.196%
Kodiak Sciences Inc. 181.63 Million USD 99.631%
Sana Biotechnology, Inc. 104.09 Million USD 99.355%
Annexon, Inc. 31.35 Million USD 97.86%
Adverum Biotechnologies, Inc. 75.03 Million USD 99.106%
Assembly Biosciences, Inc. 2.34 Million USD 71.349%
Elicio Therapeutics, Inc. 6.91 Million USD 90.299%
Moderna, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. 13.85 Million USD 95.155%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 99.954%
Vor Biopharma Inc. 35.66 Million USD 98.118%
Eyenovia, Inc. 16.1 Million USD 95.834%
DiaMedica Therapeutics Inc. 400 Thousand USD -67.75%
Puma Biotechnology, Inc. 111.49 Million USD 99.398%
Monte Rosa Therapeutics, Inc. 46.03 Million USD 98.543%
Wave Life Sciences Ltd. 32.11 Million USD 97.911%
Conduit Pharmaceuticals Inc. 985 Thousand USD 31.878%
ACADIA Pharmaceuticals Inc. 57.2 Million USD 98.827%
Immunocore Holdings plc 84.03 Million USD 99.201%
Tango Therapeutics, Inc. 38.92 Million USD 98.276%
Galectin Therapeutics Inc. 71.8 Million USD 99.066%
Alkermes plc 290.73 Million USD 99.769%
Arcellx, Inc. 97.62 Million USD 99.313%
Renovaro Biosciences Inc. 2.45 Million USD 72.623%
Zentalis Pharmaceuticals, Inc. 45.77 Million USD 98.534%
Sagimet Biosciences Inc. 65 Thousand USD -932.308%
Regulus Therapeutics Inc. 3.1 Million USD 78.369%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 46.789%
Moolec Science SA 2.64 Million USD 74.634%
Biomea Fusion, Inc. 10.29 Million USD 93.483%
RenovoRx, Inc. - USD -Infinity%
Geron Corporation 85.89 Million USD 99.219%
Mereo BioPharma Group plc 5.95 Million USD 88.726%
Verrica Pharmaceuticals Inc. 45.51 Million USD 98.526%
Royalty Pharma plc 6.13 Billion USD 99.989%
Atea Pharmaceuticals, Inc. 2.4 Million USD 72.065%
Greenwich LifeSciences, Inc. - USD -Infinity%
Calithera Biosciences, Inc. 1.66 Million USD 59.724%
TFF Pharmaceuticals, Inc. 115.25 Thousand USD -482.192%
Mersana Therapeutics, Inc. 33.83 Million USD 98.017%
Humacyte, Inc. 58.1 Million USD 98.845%
Structure Therapeutics Inc. 5.45 Million USD 87.695%
NLS Pharmaceutics AG 1.63 Million USD 58.929%
Genelux Corporation 2.51 Million USD 73.362%
ESSA Pharma Inc. 80.32 Thousand USD -735.325%
aTyr Pharma, Inc. 15.09 Million USD 95.555%
Notable Labs, Ltd. 2.04 Million USD 67.252%
Alzamend Neuro, Inc. 300.71 Thousand USD -123.136%
Mustang Bio, Inc. 2.49 Million USD 73.139%
Immunovant, Inc. 138 Thousand USD -386.232%
Tevogen Bio Holdings Inc. 1.63 Million USD 58.878%
Vericel Corporation 88.14 Million USD 99.239%
Halozyme Therapeutics, Inc. 1.49 Billion USD 99.955%
Akari Therapeutics, Plc - USD -Infinity%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Vaxcyte, Inc. 29.22 Million USD 97.704%
Orgenesis Inc. 22.62 Million USD 97.034%
Spruce Biosciences, Inc. 4.6 Million USD 85.442%
NeuroBo Pharmaceuticals, Inc. 203 Thousand USD -230.542%
GH Research PLC 343 Thousand USD -95.627%
Tempest Therapeutics, Inc. 20.66 Million USD 96.752%
PepGen Inc. 20.1 Million USD 96.662%
Moleculin Biotech, Inc. 574 Thousand USD -16.899%
Relmada Therapeutics, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. - USD -Infinity%
Telomir Pharmaceuticals, Inc. Common Stock 101 Thousand USD -564.356%
Belite Bio, Inc 886 Thousand USD 24.266%
Pharming Group N.V. 171.54 Million USD 99.609%
XOMA Corporation 124.45 Million USD 99.461%
Reneo Pharmaceuticals, Inc. 973 Thousand USD 31.038%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited 239.61 Million USD 99.72%
Xencor, Inc. 83.43 Million USD 99.196%
Replimune Group, Inc. 75.86 Million USD 99.116%
Pyxis Oncology, Inc. 21.33 Million USD 96.854%
Cassava Sciences, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 9.4 Million USD 92.865%
Estrella Immunopharma, Inc. - USD -Infinity%
Turnstone Biologics Corp. 3.21 Million USD 79.123%
Windtree Therapeutics, Inc. 16.83 Million USD 96.013%
GeoVax Labs, Inc. - USD -Infinity%
MEI Pharma, Inc. - USD -Infinity%
Olema Pharmaceuticals, Inc. 2.41 Million USD 72.238%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 46.789%
Bio-Path Holdings, Inc. 113 Thousand USD -493.805%
Enlivex Therapeutics Ltd. 1.03 Million USD 34.981%
CollPlant Biotechnologies Ltd. 3.15 Million USD 78.759%
scPharmaceuticals Inc. 40.26 Million USD 98.334%
HilleVax, Inc. 51.19 Million USD 98.689%
Vera Therapeutics, Inc. 53.7 Million USD 98.751%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
SeaStar Medical Holding Corporation 9.08 Million USD 92.611%
Immunic, Inc. 1.33 Million USD 49.7%
Atossa Therapeutics, Inc. - USD -Infinity%
Aptorum Group Limited 3.36 Million USD 80.044%
Soleno Therapeutics, Inc. 403 Thousand USD -66.501%
SeaStar Medical Holding Corporation 9.08 Million USD 92.611%
OKYO Pharma Limited - USD -Infinity%
Carmell Therapeutics Corporation 2.13 Million USD 68.593%
Achieve Life Sciences, Inc. 16.73 Million USD 95.989%
Ocean Biomedical, Inc. 2.15 Million USD 68.791%
Amicus Therapeutics, Inc. 445.05 Million USD 99.849%
Salarius Pharmaceuticals, Inc. 289.64 Thousand USD -131.664%
bluebird bio, Inc. 330.32 Million USD 99.797%
DBV Technologies S.A. 14.38 Million USD 95.334%
Compugen Ltd. 1.35 Million USD 50.333%
Protagenic Therapeutics, Inc. - USD -Infinity%
Peak Bio, Inc. 10.72 Million USD 93.742%
Vincerx Pharma, Inc. 2.5 Million USD 73.181%
Fresh Tracks Therapeutics, Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. 6.2 Million USD 89.191%
Orchestra BioMed Holdings, Inc. 1.68 Million USD 60.225%
Zevra Therapeutics, Inc. 42.76 Million USD 98.431%
Acrivon Therapeutics, Inc. Common Stock 4.64 Million USD 85.551%
Benitec Biopharma Inc. 284 Thousand USD -136.268%
Spyre Therapeutics, Inc. 84.55 Million USD 99.206%
Adicet Bio, Inc. 20.92 Million USD 96.793%
Prime Medicine, Inc. 13.63 Million USD 95.078%
Aditxt, Inc. 18.21 Million USD 96.317%
Madrigal Pharmaceuticals, Inc. 117.19 Million USD 99.427%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 15.3 Million USD 95.615%
GlycoMimetics, Inc. 808.4 Thousand USD 16.997%
PolyPid Ltd. 11.77 Million USD 94.303%
Aileron Therapeutics, Inc. 91.45 Million USD 99.266%
Invivyd, Inc. 2.16 Million USD 69.007%
Quoin Pharmaceuticals, Ltd. 3523.73 USD -18942.322%
Rigel Pharmaceuticals, Inc. 60.57 Million USD 98.892%
CorMedix Inc. 667.63 Thousand USD -0.504%
Instil Bio, Inc. 86.05 Million USD 99.22%
Recursion Pharmaceuticals, Inc. 50.67 Million USD 98.676%
Contineum Therapeutics, Inc. Class A Common Stock 193.19 Million USD 99.653%
Finch Therapeutics Group, Inc. 30.12 Million USD 97.773%
Spero Therapeutics, Inc. 5.54 Million USD 87.895%
Alpha Tau Medical Ltd. 13.27 Million USD 94.946%
AbCellera Biologics Inc. 77.38 Million USD 99.133%
Ocular Therapeutix, Inc. 83.38 Million USD 99.195%
Surrozen, Inc. 3.37 Million USD 80.142%
Janux Therapeutics, Inc. 24.54 Million USD 97.266%
Verona Pharma plc 51.32 Million USD 98.693%
Terns Pharmaceuticals, Inc. 603 Thousand USD -11.277%
Vir Biotechnology, Inc. 124.54 Million USD 99.461%
Evaxion Biotech A/S 10.86 Million USD 93.827%
Verve Therapeutics, Inc. 74.9 Million USD 99.104%
Shattuck Labs, Inc. 4.2 Million USD 84.031%
AlloVir, Inc. 27.42 Million USD 97.554%
BioVie Inc. 6.11 Million USD 89.021%
Codexis, Inc. 22.36 Million USD 97.0%
SELLAS Life Sciences Group, Inc. 906 Thousand USD 25.938%
Lexaria Bioscience Corp. 163.96 Thousand USD -309.229%
Agenus Inc. 350.24 Million USD 99.808%
Virax Biolabs Group Limited 224.3 Thousand USD -199.153%
Lantern Pharma Inc. 234.47 Thousand USD -186.176%
Viridian Therapeutics, Inc. 21.04 Million USD 96.812%
eFFECTOR Therapeutics, Inc. 19.44 Million USD 96.549%
Immix Biopharma, Inc. - USD -Infinity%
Celcuity Inc. 37.44 Million USD 98.208%
Cardiff Oncology, Inc. 2.14 Million USD 68.776%
Acumen Pharmaceuticals, Inc. 28.48 Million USD 97.645%
IN8bio, Inc. 4.89 Million USD 86.287%
Avenue Therapeutics, Inc. - USD -Infinity%
Trevi Therapeutics, Inc. 1.33 Million USD 49.851%
Lexicon Pharmaceuticals, Inc. 106.06 Million USD 99.367%
Liquidia Corporation 3.5 Million USD 80.845%
Quantum-Si incorporated 15.3 Million USD 95.615%
Pasithea Therapeutics Corp. 81.68 Thousand USD -721.499%
Xenon Pharmaceuticals Inc. 10.9 Million USD 93.846%
Sol-Gel Technologies Ltd. 1.65 Million USD 59.407%
United Therapeutics Corporation 700 Million USD 99.904%
Solid Biosciences Inc. 26.26 Million USD 97.445%
Immuneering Corporation 4.46 Million USD 84.965%
Alpha Tau Medical Ltd. 13.27 Million USD 94.946%
uniQure N.V. 138.4 Million USD 99.515%
Xilio Therapeutics, Inc. 11.45 Million USD 94.143%
Enveric Biosciences, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 85.42 Million USD 99.214%
Longboard Pharmaceuticals, Inc. 475 Thousand USD -41.263%
PMV Pharmaceuticals, Inc. 13.28 Million USD 94.95%
Elevai Labs, Inc. Common Stock 210.48 Thousand USD -218.782%
Cue Biopharma, Inc. 14.69 Million USD 95.434%
Nuvectis Pharma, Inc. - USD -Infinity%
ARS Pharmaceuticals, Inc. 274 Thousand USD -144.891%
Zura Bio Limited - USD -Infinity%
Forte Biosciences, Inc. - USD -Infinity%
Elevation Oncology, Inc. 30.13 Million USD 97.774%
Conduit Pharmaceuticals Inc. 985 Thousand USD 31.878%
Immunome, Inc. 1.65 Million USD 59.333%
Compass Therapeutics, Inc. 1.73 Million USD 61.281%
enGene Holdings Inc. Warrants 9.77 Million USD 93.138%
Inovio Pharmaceuticals, Inc. 30.2 Million USD 97.779%
LENZ Therapeutics, Inc. 362 Thousand USD -85.359%
Milestone Pharmaceuticals Inc. 51.77 Million USD 98.704%
Rallybio Corporation 392 Thousand USD -71.173%
Plus Therapeutics, Inc. 4.18 Million USD 83.951%
Dianthus Therapeutics, Inc. 585 Thousand USD -14.701%
Moolec Science SA 2.64 Million USD 74.634%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Tourmaline Bio, Inc. 415 Thousand USD -61.687%
NeurAxis, Inc. 224.26 Thousand USD -199.206%
Maravai LifeSciences Holdings, Inc. 610.96 Million USD 99.89%
Lumos Pharma, Inc. 6.58 Million USD 89.81%
enGene Holdings Inc. Common Stock 9.77 Million USD 93.138%
180 Life Sciences Corp. 1.32 Million USD 49.169%
NKGen Biotech, Inc. Warrants 19.92 Million USD 96.632%
Opiant Pharmaceuticals, Inc. 17.08 Million USD 96.071%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 56.849%
Nutriband Inc. 241.28 Thousand USD -178.094%
CG Oncology, Inc. Common stock 826 Thousand USD 18.765%
argenx SE 20 Million USD 96.645%
Neurogene Inc. 16.25 Million USD 95.872%
Mirum Pharmaceuticals, Inc. 308.14 Million USD 99.782%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock 28.54 Million USD 97.649%
Sesen Bio, Inc. - USD -Infinity%
AnaptysBio, Inc. 17.81 Million USD 96.233%
Design Therapeutics, Inc. 3.05 Million USD 78.0%
Leap Therapeutics, Inc. 262 Thousand USD -156.107%
Seelos Therapeutics, Inc. 14.22 Million USD 95.284%
Achilles Therapeutics plc 4.61 Million USD 85.46%
NeuroSense Therapeutics Ltd. 142 Thousand USD -372.535%
ORIC Pharmaceuticals, Inc. 10.21 Million USD 93.43%
Fractyl Health, Inc. Common Stock 373.72 Million USD 99.82%
Rani Therapeutics Holdings, Inc. 30.09 Million USD 97.771%
MoonLake Immunotherapeutics 3.69 Million USD 81.854%
Palisade Bio, Inc. 369 Thousand USD -81.843%
Beam Therapeutics Inc. 173.17 Million USD 99.613%
AEON Biopharma, Inc. 278 Thousand USD -141.367%
Enliven Therapeutics, Inc. 335 Thousand USD -100.299%
Kiora Pharmaceuticals, Inc. 106.89 Thousand USD -527.742%
Iovance Biotherapeutics, Inc. 75.86 Million USD 99.115%
Taysha Gene Therapies, Inc. 61.1 Million USD 98.902%
Athira Pharma, Inc. 1.58 Million USD 57.666%
Vaccinex, Inc. 247 Thousand USD -171.66%
HCW Biologics Inc. 6.45 Million USD 89.6%
XOMA Corporation 124.45 Million USD 99.461%
Nektar Therapeutics 230.4 Million USD 99.709%
Arvinas, Inc. 3.4 Million USD 80.265%
Tevogen Bio Holdings Inc. 1.63 Million USD 58.878%
Merus N.V. 12.16 Million USD 94.483%
Omega Therapeutics, Inc. 128.42 Million USD 99.478%
Quince Therapeutics, Inc. 13.81 Million USD 95.143%
Rezolute, Inc. 2.22 Million USD 69.883%
Clene Inc. 32.16 Million USD 97.914%
Indaptus Therapeutics, Inc. 175.05 Thousand USD -283.312%
BeyondSpring Inc. 3.99 Million USD 83.204%
Synlogic, Inc. 17.27 Million USD 96.116%
Allarity Therapeutics, Inc. 1.3 Million USD 48.385%
Phio Pharmaceuticals Corp. 35 Thousand USD -1817.143%
Peak Bio, Inc. 10.72 Million USD 93.742%
Werewolf Therapeutics, Inc. 51.92 Million USD 98.708%
Krystal Biotech, Inc. 8.09 Million USD 91.71%
Karyopharm Therapeutics Inc. 177.01 Million USD 99.621%
SpringWorks Therapeutics, Inc. 7.05 Million USD 90.492%
Lipella Pharmaceuticals Inc. 136.59 Thousand USD -391.237%
MannKind Corporation 382.37 Million USD 99.825%
Ikena Oncology, Inc. 10.73 Million USD 93.751%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 409 Thousand USD -64.059%
Gossamer Bio, Inc. 212.46 Million USD 99.684%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. 174 Thousand USD -285.632%
NRx Pharmaceuticals, Inc. 9.16 Million USD 92.675%
Legend Biotech Corporation 328.67 Million USD 99.796%
Mural Oncology plc 15 Million USD 95.529%
Biora Therapeutics, Inc. 47.42 Million USD 98.585%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. 2.1 Million USD 68.063%
Champions Oncology, Inc. 7.43 Million USD 90.969%
REGENXBIO Inc. 89.29 Million USD 99.249%
Ensysce Biosciences, Inc. 854.69 Thousand USD 21.493%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. 552.98 Thousand USD -21.342%
Edgewise Therapeutics, Inc. 5.41 Million USD 87.606%
Vaxart, Inc. 26.51 Million USD 97.469%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. 15.65 Million USD 95.714%
Cellectis S.A. 92.85 Million USD 99.277%
Longeveron Inc. 2.04 Million USD 67.124%
Repare Therapeutics Inc. 3.41 Million USD 80.323%
Sarepta Therapeutics, Inc. 1.39 Billion USD 99.952%
Inozyme Pharma, Inc. 46.59 Million USD 98.56%
Revolution Medicines, Inc. 87.94 Million USD 99.237%
Nymox Pharmaceutical Corporation 173 Thousand USD -287.861%
Third Harmonic Bio, Inc. 3.95 Million USD 83.026%
ArriVent BioPharma, Inc. Common Stock 317 Thousand USD -111.672%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 175 Thousand USD -283.429%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 99.917%
Denali Therapeutics Inc. 52.24 Million USD 98.716%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 14.4 Million USD 95.342%
Corvus Pharmaceuticals, Inc. 1.37 Million USD 51.164%
Cingulate Inc. 3.13 Million USD 78.597%
Passage Bio, Inc. 26.29 Million USD 97.448%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. 6.66 Million USD 89.932%
Day One Biopharmaceuticals, Inc. 408 Thousand USD -64.461%
Oramed Pharmaceuticals Inc. 894 Thousand USD 24.944%
Revolution Medicines, Inc. Warrant 87.94 Million USD 99.237%
Scinai Immunotherapeutics Ltd. 20.56 Million USD 96.737%
Rhythm Pharmaceuticals, Inc. 1.26 Million USD 46.746%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 2.45 Million USD 72.625%
Carisma Therapeutics, Inc. 3.12 Million USD 78.514%
Unicycive Therapeutics, Inc. 811 Thousand USD 17.263%
OmniAb, Inc. 25.56 Million USD 97.375%
Anew Medical, Inc. 1.6 Million USD 58.193%
Fennec Pharmaceuticals Inc. 29.58 Million USD 97.732%
Lipocine Inc. 17.16 Thousand USD -3808.89%
Lexeo Therapeutics, Inc. Common Stock 11.63 Million USD 94.234%
Nautilus Biotechnology, Inc. 34.62 Million USD 98.062%
SAB Biotherapeutics, Inc. 5.9 Million USD 88.641%
G1 Therapeutics, Inc. 57.17 Million USD 98.826%
Bellerophon Therapeutics, Inc. 203 Thousand USD -230.542%
Sage Therapeutics, Inc. 5.16 Million USD 87.009%
Ocugen, Inc. 6.94 Million USD 90.333%
Mind Medicine (MindMed) Inc. 14.12 Million USD 95.251%
Q32 Bio Inc. 1.31 Million USD 49.09%
Brainstorm Cell Therapeutics Inc. 672 Thousand USD 0.149%
Alumis Inc. Common Stock 32.58 Million USD 97.94%
Equillium, Inc. 824 Thousand USD 18.568%
Kyverna Therapeutics, Inc. 9.07 Million USD 92.609%
Coya Therapeutics, Inc. - USD -Infinity%
CNS Pharmaceuticals, Inc. 300.8 Thousand USD -123.067%
Galera Therapeutics, Inc. 152.29 Million USD 99.559%
Evelo Biosciences, Inc. 51.13 Million USD 98.688%
Comera Life Sciences Holdings, Inc. 775.04 Thousand USD 13.425%
Dominari Holdings Inc. 3.02 Million USD 77.84%
Edesa Biotech, Inc. 94.48 Thousand USD -610.151%
vTv Therapeutics Inc. 529 Thousand USD -26.843%
Bio-Techne Corporation 419.53 Million USD 99.84%
Agios Pharmaceuticals, Inc. 71.99 Million USD 99.068%
Harmony Biosciences Holdings, Inc. 193.56 Million USD 99.653%
Prelude Therapeutics Incorporated 16.88 Million USD 96.027%
Candel Therapeutics, Inc. 22.76 Million USD 97.052%
iTeos Therapeutics, Inc. 6.05 Million USD 88.924%
Nkarta, Inc. 88.33 Million USD 99.24%
BioCardia, Inc. 1.31 Million USD 48.973%
Iterum Therapeutics plc 19.5 Million USD 96.561%